HWH INTERNATIONAL INC. Cost of Revenue
HWH INTERNATIONAL INC. (HWH) reported Cost of Revenue of $43.84 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-07-30
- HWH INTERNATIONAL INC. cost of revenue for the quarter ending 2026-06-30 was $43.84K, a 83.54% decline year-over-year.
- HWH INTERNATIONAL INC. cost of revenue for the quarter ending 2026-03-31 was $16.91K, a 88.54% decline year-over-year.
- HWH INTERNATIONAL INC. cost of revenue for the quarter ending 2025-12-31 was $14.90K, a 91.40% decline year-over-year.
- HWH INTERNATIONAL INC. cost of revenue for the quarter ending 2025-09-30 was $83.20K, a 55.19% decline year-over-year.
- HWH INTERNATIONAL INC. cost of revenue for fiscal 2025 was $407.20K, a 37.52% decline from fiscal 2024.
- HWH INTERNATIONAL INC. cost of revenue for fiscal 2024 was $651.72K, a 94.65% increase from fiscal 2023.
- HWH INTERNATIONAL INC. cost of revenue for fiscal 2023 was $334.82K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43.84K 10-Q · filed 2026-07-30 | $102.25K 10-Q · filed 2026-07-30 | $75.65K derived: sum of 3 quarters · filed 2026-07-30 | $158.84K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $16.91K 10-Q · filed 2026-05-13 | $31.81K derived: sum of 2 quarters · filed 2026-05-13 | $115.01K derived: sum of 3 quarters · filed 2026-05-13 | $381.32K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $14.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $98.09K derived: sum of 2 quarters · filed 2026-03-26 | $364.41K derived: sum of 3 quarters · filed 2026-07-30 | $407.20K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $83.20K 10-Q · filed 2025-10-22 | $349.51K derived: sum of 2 quarters · filed 2026-07-30 | $392.30K 10-Q · filed 2025-10-22 | $670.40K derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $266.31K 10-Q · filed 2026-07-30 | $161.50K 10-Q · filed 2025-08-14 | $529.08K 10-Q · filed 2026-07-30 | $309.10K 10-Q · filed 2025-08-14 | $587.20K derived: sum of 3 quarters · filed 2026-07-30 | $772.86K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $147.60K 10-Q · filed 2026-05-13 | $320.89K derived: sum of 2 quarters · filed 2026-05-13 | $506.54K derived: sum of 3 quarters · filed 2026-05-13 | $676.51K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $173.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $358.94K derived: sum of 2 quarters · filed 2026-03-26 | $528.91K derived: sum of 3 quarters · filed 2026-03-26 | $651.72K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $185.65K 10-Q · filed 2025-10-22 | $355.62K derived: sum of 2 quarters · filed 2025-10-22 | $478.44K 10-Q · filed 2025-10-22 | $575.44K derived: sum of 4 quarters · filed 2025-10-22 | ||
| 2024-06-30 | $169.97K 10-Q · filed 2025-08-14 | $292.78K 10-Q · filed 2025-08-14 | $389.78K derived: sum of 3 quarters · filed 2025-08-14 | $476.22K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $122.81K 10-Q · filed 2025-05-15 | $219.81K derived: sum of 2 quarters · filed 2025-05-15 | $306.25K derived: sum of 3 quarters · filed 2025-05-15 | $379.87K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $183.44K derived: sum of 2 quarters · filed 2025-03-31 | $257.06K derived: sum of 3 quarters · filed 2025-03-31 | $334.82K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $86.44K 10-Q · filed 2024-11-06 | $160.06K derived: sum of 2 quarters · filed 2024-11-06 | $237.82K 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $73.62K 10-Q · filed 2024-08-12 | $151.39K 10-Q · filed 2024-08-12 | ||||
| 2023-03-31 | $77.77K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |